A new medical use of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate and natural flavonoid derivatives
- 专利权人:
- 发明人:
- 申请号：
- EP10173254.3
- 公开号：
- EP2425835A1
- 申请日:
- 2010.08.18
- 申请国别(地区):
- EP
- 年份:
- 2012
- 代理人:
- 摘要：
- The present invention relates to highly effective treatment of cancer with 3-(2,2,2-trimethylhydrazinium) propionate dihydrate or its pharmaceutically acceptable salts and naturally occuring flavonoids, preferably Caffeic acid phenethyl ester and (+)-Catechin.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Composition of caffeic acid phenethyl ester (CAPE) and one of catechin, kaempherol and myricetin for potentiating antitumour effect and for treating tumours
- Composition of TEGAFUR, caffeic acid phenethyl ester (CAPE) and either catechin, kaempherol, myricetin or luteolin for potentiating antitumour effect and for treating tumours
- PHARMACEUTICAL COMBINATION OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL AND CAFFEIC ACID PHENETHYL ESTER FOR ORAL TREATING OF TUMORS
- PROPOLIS AND CAFFEIC ACID PHENETHYL ESTER AND USES THEREOF
- Composition for preventing or treating immune disease comprising Caffeic acid phenethyl ester
